RxDoctor Payments Data

Sena Durakovic, MD

Family Medicine · Jacksonville, FLNPI 1497041701

Payments from drug & device makers

$3,025in general payments, 2019–2025

Across 217 payments — averaging $13.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$247
  • AbbVie$236
  • Sanofi-aventis U.S. LLC$154
  • Boehringer Ingelheim$138
  • Merck$128
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,019100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,025 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$68,315
Medicare patients
242
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide93$151,484
MounjaroTirzepatide44$59,098
JardianceEmpagliflozin55$56,525
EliquisApixaban28$46,781
TrulicityDulaglutide31$33,949
XareltoRivaroxaban24$24,910
LinzessLinaclotide17$23,501
FarxigaDapagliflozin Propanediol17$22,822
JanuviaSitagliptin Phosphate12$21,058
MyrbetriqMirabegron23$12,006
Nurtec OdtRimegepant Sulfate11$11,724
TradjentaLinagliptin11$9,545
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$7,594
SymbicortBudesonide/Formoterol Fumarate13$4,567
SynthroidLevothyroxine Sodium31$3,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,108$151,48493 claims
Lilly USA, LLCMounjaro, Trulicity$42$93,04875 claims
Boehringer IngelheimJardiance, Tradjenta$138$66,07066 claims
PfizerEliquis, Nurtec Odt$64$58,50539 claims
AstraZenecaFarxiga, Symbicort$247$27,38930 claims
AbbVieLinzess, Synthroid$236$26,53748 claims
MerckJanuvia$128$21,05812 claims
Astellas Pharma US IncMyrbetriq$110$12,00623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →